The prognosis of patients treated with everolimus for advanced ER‐positive, HER2‐negative breast cancer is driven by molecular features
Article in The Journal of Pathology Clinical Research (April 2024)
The most recent citing publications are shown below. View all 84 publications that cite this research output on Dimensions.
Article in The Journal of Pathology Clinical Research (April 2024)
Preprint in bioRxiv (March 2024)
Article in American Journal of Cancer Research (January 2024)